|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Human T-Cadherin(130K) ELISA | Androstenedione ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Complement System MBL Pathway ELISA Assay | Vitamin D, 25-OH Total RIA CT Assay |
| Citations | | | | | |
| Catalog Number | 27364 | IB79119 | TM09036 | COMPL MP320 RUO | KIR1971 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA designed for the determination of T-Cadherin (130k) in human serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme-linked immunosorbent assay (ELISA) for the determination of Androstenedione in serum and EDTA plasma. FDA exempt, can be used for in-vitro diagnostics. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Wieslab® COMPL MP320 kit is an enzyme immunoassay for the determination of MBL complement pathway in human serum. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of 25-hydroxyvitamin D3 and D2 (25-OH-D3 and 25-OH-D2) in serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Human T-Cadherin(130K) | 1,3,5(10)-estratriene-3,17ß-diol; 17ß-estradiol; E2. | sAPP Total | Human secreted Alpha Klotho (a-Klotho) | LRG |
| Sample Type | Serum, Blood Plasma | Human serum or plasma (EDTA, lithium heparin, or citrate plasma). | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, EDTA-plasma, and cerebrospinal fluid (CSF). | Serum, Blood Plasma, Urine, CSF |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | 0/ 0.03 - 2 ng/mL | 0.1 to 10.0 ng/mL | Anti-Ustekinumab (Stelara®) | Inquire | 10 to 100 ng/mL |
| Sensitivity | 90.91% (95% confidence interval: 58.72% - 99.77%) | 10.6 pg/mL | 0.06 ng/mL | 9.87 pg/mL | 0.17 ng/mL |
| Assay Time | 90 min. (37°C) + 30 min. (2-8°C) + 30 min. (RT) = 2 hours total incubation time. | 1 hr 30 mins (incubation) | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) | 3 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |